Search Results Search Sort by RelevanceMost Recent Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 1 Charles Weijer, MD, PhD Virtual Mentor. 2004;6(11):482-484. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411. Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 2 Karen Kreiner, MD Virtual Mentor. 2004;6(11):484-485. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411. Case and Commentary Aug 2017 How Should Physicians Help Gender-Transitioning Adolescents Consider Potential Iatrogenic Harms of Hormone Therapy? Thomas D. Steensma, PhD, S. Annelijn Wensing-Kruger, MSc, and Daniel T. Klink, MD, PhD Adolescents with gender dysphoria should be active participants in decisions about their gender-related health care. AMA J Ethics. 2017;19(8):762-770. doi: 10.1001/journalofethics.2017.19.8.ecas3-1708.
Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 1 Charles Weijer, MD, PhD Virtual Mentor. 2004;6(11):482-484. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411.
Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 2 Karen Kreiner, MD Virtual Mentor. 2004;6(11):484-485. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411.
Case and Commentary Aug 2017 How Should Physicians Help Gender-Transitioning Adolescents Consider Potential Iatrogenic Harms of Hormone Therapy? Thomas D. Steensma, PhD, S. Annelijn Wensing-Kruger, MSc, and Daniel T. Klink, MD, PhD Adolescents with gender dysphoria should be active participants in decisions about their gender-related health care. AMA J Ethics. 2017;19(8):762-770. doi: 10.1001/journalofethics.2017.19.8.ecas3-1708.